Actinogen Medical
Lee Bergman is a seasoned professional with extensive experience in regulatory and medical writing, project management, and scientific research. Currently serving as a Regulatory and Medical Writing Scientist at Actinogen Medical since November 2021, Lee has previously held roles as a Medical Writer at Novotech and a Manager at Queensland Health. Lee's leadership capabilities were demonstrated during tenure as Assistant Director at the Therapeutic Goods Administration, where responsibilities included directing strategic projects and performance reporting. With a strong academic background, including a Doctor of Philosophy in Cellular and Molecular Biology and a Master of Business Administration, Lee has contributed to significant projects in the biomedical field while also advancing knowledge through research initiatives at institutions such as the University of Southampton and the German Cancer Research Center.
This person is not in any offices
Actinogen Medical
1 followers
FOCUSED ON DEVELOPING AN INNOVATIVE TREATMENT FOR COGNITIVE IMPAIRMENT due to raised cortisol ASSOCIATED WITH NEUROLOGICAL DISEASES Ethics Committee approval for XanaMIA StudyActinogen has received approval from the Bellberry Human Research Ethics Comm...